Michael J. Manos, MD, PhD, Head of the Center for Pediatric Behavioral Health, Children’s Hospital, Cleveland Clinic, discusses ADHD and describes some of the benefits of having this…
NEW YORK (Reuters Health) – The reported sensitivity of numerous blood-based markers proposed for the early detection of colorectal cancer (CRC) are probably higher than might be expected…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
Francis G. Spinale, MD, PhD, Medical University of South Carolina, discusses controlling BP using biomarkers to tell us if we should add on antihypertensive therapy. Related Reading Angiotensin-(1-7)…
NEW YORK (Reuters Health) – When sepsis is suspected in a newborn infant, a complete blood count as a test for infection improves “dramatically” with increasing time over…
NEW YORK (Reuters Health) – A population-based study from Scotland shows that fewer than one in every 100 patients with subclinical hyperthyroidism will progress to overt hyperthyroidism. In…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
NEW YORK (Reuters Health) – Among women treated for endometrial hyperplasia, regression rates appear to be better with the levonorgestrel-releasing intrauterine system than with oral progestogen treatment, according…
NEW YORK (Reuters Health) – The GLP-1 receptor agonist exenatide used to treat type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) events, compared…